REVH
Revolution Healthcare Acquisition Corp. [REVH] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
REVH Stock Summary
In the News
REVH Financial details
Company Rating
Neutral
Market Cap
0
Income
13380.17B
Revenue
0
Book val./share
-0.33
Cash/share
0.03
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-30.7
P/C
334.83
P/FCF
-
Quick Ratio
2.18
Current Ratio
2.68
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
231.69K
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
33.98%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
87.34%
Inst Trans
1.05%
ROA
2410684%
ROE
-60626532%
ROC
-1439.28%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.62-10.5
52W High
+0.45%
52W Low
+11.61%
RSI
54
Rel Volume
-
Avg Volume
388.73K
Volume
371
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
0%
Price
10.045
Change
0.05%
REVH Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2021-12-31 |
|---|---|---|
| 2.02K | ||
| Revenue per share | 0 | |
| Net income per share | 0.8 | |
| Operating cash flow per share | -0.05 | |
| Free cash flow per share | -0.05 | |
| Cash per share | 0.06 | |
| Book value per share | -0.56 | |
| Tangible book value per share | 8.96 | |
| Share holders equity per share | -0.56 | |
| Interest debt per share | 0.02 | |
| Market cap | 562.49M | |
| Enterprise value | 559.11M | |
| P/E ratio | 12.11 | |
| Price to sales ratio | 0 | |
| POCF ratio | -194.68 | |
| PFCF ratio | -194.68 | |
| P/B Ratio | -17.29 | |
| PTB ratio | -17.29 | |
| EV to sales | 0 | |
| Enterprise value over EBITDA | 24.56 | |
| EV to operating cash flow | -193.51 | |
| EV to free cash flow | -193.51 | |
| Earnings yield | 0.08 | |
| Free cash flow yield | -0.01 | |
| Debt to equity | 0 | |
| Debt to assets | 0 | |
| Net debt to EBITDA | -0.15 | |
| Current ratio | 15.11 | |
| Interest coverage | -1.65 | |
| Income quality | -0.14 | |
| Dividend Yield | 0 | |
| Payout ratio | 0 | |
| Sales general and administrative to revenue | 0 | |
| Research and developement to revenue | 0 | |
| Intangibles to total assets | 0 | |
| Capex to operating cash flow | 0 | |
| Capex to revenue | 0 | |
| Capex to depreciation | 0 | |
| Stock based compensation to revenue | 0 | |
| Graham number | 3.19 | |
| ROIC | 0.16 | |
| Return on tangible assets | 0.08 | |
| Graham Net | -0.58 | |
| Working capital | 3.93M | |
| Tangible asset value | 517.47M | |
| Net current asset value | -32.69M | |
| Invested capital | 0 | |
| Average receivables | 0 | |
| Average payables | 0 | |
| Average inventory | 0 | |
| Days sales outstanding | 0 | |
| Days payables outstanding | 0 | |
| Days of inventory on hand | 0 | |
| Receivables turnover | 0 | |
| Payables turnover | 0 | |
| Inventory turnover | 0 | |
| ROE | -1.43 | |
| Capex per share | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0.19 | 0 | 231.69K | 0.08 | 0.11 | |
| Operating cash flow per share | -0.01 | 0 | -0.01 | 0.03 | 0 | |
| Free cash flow per share | -0.01 | 0 | -0.01 | 0.03 | 0 | |
| Cash per share | 0.07 | 0 | 0.05 | 0.04 | 0.03 | |
| Book value per share | 8.9 | 0 | -0.45 | -0.4 | -0.33 | |
| Tangible book value per share | 8.9 | 0 | 9.07 | 9.6 | 9.71 | |
| Share holders equity per share | 8.9 | 0 | -0.45 | -0.4 | -0.33 | |
| Interest debt per share | 0 | 0 | -122.75K | -0.1 | -0.13 | |
| Market cap | 560.76M | 0 | 566.53M | 537.35M | 540.12M | |
| Enterprise value | 556.98M | -3.38M | 563.9M | 535.32M | 538.61M | |
| P/E ratio | 12.79 | 0 | 0 | 29.76 | 22.89 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -1.11K | 0 | -759.44 | 289.59 | -219.53M | |
| PFCF ratio | -1.11K | 0 | -759.44 | 289.59 | -219.53M | |
| P/B Ratio | 1.09 | 0 | -21.59 | -24.46 | -30.02 | |
| PTB ratio | 1.09 | 0 | -21.59 | -24.46 | -30.02 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 50.81 | 0 | 0 | 116.25 | 84.01 | |
| EV to operating cash flow | -1.1K | 0 | -755.92 | 288.5 | -218.91M | |
| EV to free cash flow | -1.1K | 0 | -755.92 | 288.5 | -218.91M | |
| Earnings yield | 0.02 | 0 | 23.62K | 0.01 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -0.34 | 0 | 0 | -0.44 | -0.24 | |
| Current ratio | 30.13 | 15.11 | 14.7 | 11.68 | 2.68 | |
| Interest coverage | 0 | 0 | 0.11 | 0.13 | 0.09 | |
| Income quality | -0.05 | 0 | 0 | 0.41 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 6.17 | 0 | 1.54K | 0.86 | 0.89 | |
| ROIC | 0 | 0 | 64.66K | 0.03 | 0.03 | |
| Return on tangible assets | 0.02 | 0 | 24.17K | 0.01 | 0.01 | |
| Graham Net | -0.64 | 0 | -0.47 | -0.42 | -0.35 | |
| Working capital | 4.63M | 3.93M | 3.14M | 2.35M | 1.17M | |
| Tangible asset value | 513.95M | 517.47M | 523.76M | 528.27M | 534.17M | |
| Net current asset value | -36.13M | -32.69M | -26.46M | -22.42M | -19M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 10.29K | 33.65K | 113.96K | 126.8K | 56.04K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.02 | 0 | -509.86K | -0.21 | -0.33 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
REVH Frequently Asked Questions
What is Revolution Healthcare Acquisition Corp. stock symbol ?
Revolution Healthcare Acquisition Corp. is a US stock , located in Cambridge of Ma and trading under the symbol REVH
What is Revolution Healthcare Acquisition Corp. stock quote today ?
Revolution Healthcare Acquisition Corp. stock price is $10.045 today.
Is Revolution Healthcare Acquisition Corp. stock public?
Yes, Revolution Healthcare Acquisition Corp. is a publicly traded company.
Company Profile
- Volume Average 388.73K
- CEO Mr. Jay S. Markowitz M.D.
- Headquarters Cambridge,MA,US
- IPO Date 2021-05-10
-
Website
https://revolutionhealthcareacqcorp.com 
Revolution Healthcare Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in health care, life sciences, and technology industries. The company was incorporated in 2021 and is based in Cambridge, Massachusetts.
